Prospects of Using the Genetically Engineered Preparation Dupilumab for the Treatment of Atopic Dermatitis in the Adult Population. J Pak Assoc Dermatol 2022, 32 (2), 327-333. https://doi.org/10.66344/jpad.v32i2.1900.